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The influence of social processes on the timing of
cancer diagnosis: a research agenda
Jessica Corner, Lucy Brindle
ABSTRACT
This paper sets out to review the influence of social
processes on the timing of the diagnosis of cancer and to
explore the potential for promoting earlier diagnosis by
addressing social factors that influence symptom
recognition and the diagnostic process. Social processes
refer to the means by which culture and social
organisation may impact on timely cancer diagnosis. The
paper calls for concerted action around an important and
developing research agenda that may prove highly
valuable in the quest to secure prompt diagnosis for
cancer and through it improved outcomes for individuals.
Cancer survival rates have improved dramatically
over the past 30 years although they remain stub-
bornly poor among certain groups such as patients
with lung and pancreatic cancer, the socioeco-
nomically deprived and minority ethnic groups.1 2
Survival rates for cancer in the UK show improve-
ment, but remain lower than in other European
countries.3 4 Now that much has been done to
address health system performance and ensure that
treatment pathways are optimised, it is recognised
that late diagnosis is an important factor in cancer
outcomes. The recently launched UK National
Awareness and Early Detection Initiative (NAEDI)
seeks to address this.5 However, the knowledge
base or evidence to support such an initiative
remains limited.
Analysis of cancer survival data across Europe
has been undertaken to identify the relative
contribution that prompt or early diagnosis makes
to the better survival outcomes achieved in certain
European countries, notably Sweden, France, Italy,
Belgium and Switzerland and the poor relative
outcomes in the UK.6 These studies have used
1-year survival rates as a proxy measure for early
diagnosis as it is indicative of disease stage at
diagnosis. Results of the analysis indicate that for
certain cancers, notably breast and cervical cancers,
poor survival in the ﬁrst year after diagnosis
accounts for the relatively poor outcomes from the
disease compared with other countries despite the
existence of screening programmes. These poor
survival rates may be explained by small subgroups
of women diagnosed with late stage disease not
being detected by screening. For other cancers, such
as lung cancer, there is poor relative 1-year and
5-year survival, suggesting that both late diagnosis
and access to optimum treatment and care may
account for the differences.7 Variation in screening
coverage and participation rates across Europe
might account for some of the variation in survival
outcomes. However, even when there are well
organised national screening programmes with high
participation, many tumours are diagnosed
following symptomatic presentation rather than
screening.8 Analyses of cancer survival data have
provided greater understanding as to the extent of
late diagnosis and its contribution to outcomes in
cancer survival, and a recognition that focusing on
promoting earlier diagnosis, alongside and in addi-
tion to cancer screening programmes, needs to be
given greater emphasis.
These analyses have led to an emergent science
about what promotes or inhibits timely (early)
diagnosis of cancer as well as developing a deeper
understanding of the dynamic around the processes
of becoming diagnosed with cancer and the rela-
tionship between promoting earlier diagnosis with
improved outcomes for the disease. Emergent
concepts, informed by social and psychological
sciences as well as clinical science, are inﬂuencing
policy development and research agendas. These are
delayed diagnosis, cancer awareness and lay and
professional symptom recognition. In each of these
areas work is underway or has been completed to
develop insights into the contribution each might
make to cancer survival outcomes and to investi-
gate potential intervention strategies to promote
earlier diagnosis.
DELAY
Burgess et al9 identify three types of delay in the
diagnosis of cancer: ﬁrst, that generated by the
individual who fails to act on suspicious symptoms
through fear, lack of knowledge or because they do
not interpret their symptoms as being serious.
Second, doctor or practitioner-generated delay that
occurs through misinterpreting symptoms or not
initiating referral for diagnostic tests. Third, system
or hospital-generated delay that occurs through
inefﬁciency, or long waiting times for appoint-
ments or tests. These three types of delay have
been operationalised for measurement purposes in
studies as patient delay (the time between ﬁrst
noticing symptoms and ﬁrst consulting a doctor),
practitioner delay (the interval between ﬁrst
consultation and referral) and hospital delay (the
time between referral and diagnosis).10 A growing
number of studies has attempted to determine the
length of delay occurring for each of these phases.
Systematic reviews of delay in upper gastrointes-
tinal cancer diagnosis and colorectal cancer diag-
nosis indicate patient delays ranging from 7 days to
7.5 months and practitioner delays ranging from
0 to 15 months.11 12 A signiﬁcant issue in studies is
how ‘delay ’ is deﬁned and assessed making
comparisons between studies problematical. The
symptom to diagnosis interval has been used to
explore the relationship between delay, stage at
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diagnosis and survival, demonstrating a weak and cancer site-
speciﬁc relationship between this interval and survival13;
however, the deﬁnition and measurement of symptom onset is
problematical, often leading to inconclusive ﬁndings.13 14 It is
also unclear how patient factors such as behavioural responses
to symptoms may interact with the biological characteristics of
tumours.15 16 The development of referral guidelines and
performance management strategies for system-generated
waiting times has emphasised the importance of practitioner
and system delay.17 18 However, studies indicate that patient
delay and in particular ‘appraisal delay’, which is the period of
time during which an individual is trying to determine the cause
and signiﬁcance of their symptoms, may account for the greatest
proportion of delay.18e22
Factors that contribute to patient delay have been identiﬁed,
such as low symptom awareness and knowledge of the disease,
failure to interpret symptoms as problematical, incorrect self-
diagnosis and self-medication.23 The nature of the symptom
itself has been identiﬁed as important in relation to the timing
of diagnosis, and is likely to inﬂuence both the timing of
presentation and professionals’ interpretations of symptoms.
For example, even though patients presenting to emergency
services with cancer of the digestive tract have been found
to report a shorter duration of symptoms, less speciﬁc symp-
toms and fewer visits to physicians than non-emergency
admissions, most had made repeated visits to a doctor before
being admitted, indicating delay at the primary care level.14
Serious symptoms, sometimes referred to as ‘alarm’ symptoms,
are more likely to prompt early diagnosis than vague or
commonly experienced symptoms.24 Co-morbidities or multiple
symptoms can promote shorter delay as these increase concern
for individuals; however, they can also inhibit diagnosis if they
lead to the misinterpretation or masking of the symptoms of
cancer.12 25
Systematic review evidence provides insights into the body of
work examining delay in cancer diagnosis. The focus has largely
been on establishing that delay occurs, and identifying factors
that correlate with delay. Such reviews have tended to demon-
strate that the burden of delay primarily rests with individuals
who do not recognise symptoms in themselves as serious or
warranting a visit to the doctor.23 Factors such as gender,
increasing age and lower socioeconomic status, distance from
a cancer centre and lower levels of education have variously been
found to contribute to delay, although not consistently, and thus
timely diagnosis appears to have a strong socially determined
element to it. These factors are also associated with the way
individuals access hospital care for cancer.26 Methodological
differences might be blamed for inconsistencies in ﬁndings
between studies of patient delay.27 However, overcoming such
differences will not in itself provide explanations for correlations
between ‘factors’ such as socioeconomic circumstance and delay,
or provide deeper understanding of the social processes through
which these relationships are produced. Little work has been
undertaken to establish why and how delay occurs.
The suggestion that delay may be an inappropriate term is
supported by concepts arising out of the medical sociology
literature and empirical studies that indicate late cancer diag-
nosis does not always arise through a failure to act on symptoms
experienced by individuals. These studies have explained ‘late
diagnosis’ in relation to the ways in which changes in health are
interpreted by those experiencing them before their recognition
as ‘symptoms’, and suggest that the concept of delay fails to
address the complex factors at play in how individuals come to
recognise that they are ill (J Moffat, PhD thesis, 2007).22 25 28
CANCER AWARENESS
Knowledge of symptoms that might indicate cancer is recog-
nised as a prerequisite for early help-seeking and data indicate
that there is a low level of community awareness of some
symptoms of cancer as well as what to do or how to act if
symptoms arise.29 Awareness of symptoms as a sign of cancer
has been found to be low in particular groups who also have
worse health outcomes, such as the socially and economically
deprived, men and people from minority ethnic groups.29 A
national cancer awareness measure has been developed and is to
be used to monitor awareness of cancer in the UK population
over time. Interventions to raise awareness have been the
mainstay of public health intervention programmes. Most
evaluated interventions to raise awareness of cancer have been
targeted at increasing individual knowledge rather than engaging
whole communities or social systems.30 When communities
have been involved or targeted, evaluation tends to have been
limited. A healthy communities collaborative approach has been
advocated by the Department of Health for England to improve
cancer awareness and tackle late cancer diagnosis.31 This
‘community led’ approach enables community groups to
generate interventions to address health problems within their
local area.32 At the time of the NAEDI launch in 2009 the
approach was being used to promote cancer awareness in 19
primary care trusts across England. Evaluations of these
programmes, using methods traditionally used to evaluate
public health interventions, tend to be underpowered to detect
statistically signiﬁcant improvements in early diagnosis. Identi-
fying which components of complex interventions are effective
also often proves to be problematical. To date limited evidence
exists to evaluate the way such programmes may or may not be
translated into behaviour by individuals. Austoker et al,30 in
a review of the research literature, found insufﬁcient evidence
that interventions delivered to individuals promoted early
presentation and limited evidence that interventions delivered to
communities promote cancer awareness and early presentation.
Whereas underpowered studies and service evaluation reports
linked to community collaborative type projects are less likely to
be published in the research literature, making their systematic
evaluation difﬁcult, a number of community intervention
projects that indicate some success can be identiﬁed. For
example, the Early Lung Cancer Intervention in Doncaster
project (ELCID) used a social marketing approach based upon
a public awareness campaign and an intervention aimed at
general practitioners about the beneﬁts of early lung cancer
diagnosis. The stage of diagnosis changed pre and post-campaign
from 11% (stages I and II) to 19%, providing indirect evidence of
the impact of the campaign (p<0.02).33
HELP-SEEKING BEHAVIOUR
A parallel strand of work has developed and tested theory to
account for factors that promote or inhibit help-seeking behav-
iour. A number of theoretical frameworks has been proposed to
explain an individual’s predisposition to act on symptoms or
health changes they may experience. These primarily psycho-
logical theories draw on concepts such as reasoned action and
planned behaviour, as well as self-regulation theory, to explain
and predict the individual tendency to act on symptoms by
seeking medical assistance.34 For example, Bish et al35 develop
a theoretical model incorporating stages of symptom appraisal,
attitudes towards help-seeking and translating intentions into
behaviour, to explain delayed help-seeking. Whereas these
psychological models claim to identify psychological processes
and attributes of individuals that explain help-seeking, they do
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not explain the social processes and relationships within which
help-seeking takes place. In contrast, a metasynthesis of quali-
tative studies of patients’ experiences of help-seeking and delay in
cancer diagnosis36 found the main reasons for delay in help-
seeking to be difﬁculties in recognising and interpreting symp-
toms, fear of cancer and embarrassment, and gender-related
issues inhibiting help-seeking. The process of sanctioningdthat
is, those processes that legitimate actiondappeared important,
such as family members or friends encouraging or forcing contact
with health professionals; conversely, reaching crisis point with
symptoms legitimises contact with emergency services. Also
important is the process by which individuals reveal symptoms
to doctors. For example, if there is uncertainty about whether
a particular symptom or problem poses a legitimate reason to
seek medical help, individuals may instead reveal symptoms
while consulting for another problem.
DEVELOPING A BROADER RESEARCH AGENDA
The drive to develop new approaches to promoting earlier
symptomatic diagnosis as an adjunct to cancer screening
programmes is a new and emergent science. It is clear that there
is signiﬁcant potential to improve stage at diagnosis by
addressing the problem of late presentation and the concerted
effort underway should in time bear fruit. There is a growing
body of evidence on which to draw; however, a set of rather
narrow channels has been pursued to date. The focus has largely
been on the individual’s response to symptoms or bodily
changes they experience, or on professionals and professional
systems for diagnosing cancer in isolation from the wider
sociocultural context in which ideas about health, illness and
responses to illness are formed and enacted. Theoretical
approaches to the problem of late diagnosis remain ﬁrmly
within the science of the psychology of the individual or
psychosocial frames of reference. These approaches tend to
assume that delay is entirely determined through individual
decisions, judgements and behaviours, and does not then take
into consideration the wider contextual inﬂuences such as living
in a rural area or the social context in which ideas about illness,
illness causation and health system responses to illness are
constructed. Social factors are considered, but only in as far as
there may be individual characteristics that have a bearing on
behaviour such as educational or socioeconomic background.
Interventions to promote earlier diagnosis or prevent late diag-
nosis drawn from this perspective are unlikely to promote
lasting or signiﬁcant change because the environment in which
individual behaviour is shaped, and the ways in which this
environment varies across social and cultural groups, is not
addressed. Therefore we recommend the development of a third
strand of research, which focuses on the broader social dimen-
sions and processes that may impact on the timing of diagnosis.
PATIENTeHEALTH PROFESSIONAL INTERACTIONS
The intersection of lay conceptions of health and illness with
those of practitioners and health systems is important. Views of
health and ill health vary across social groups, cultures and
circumstances.28 37 38 Symptoms as they are presented in
information aimed at the public regarding awareness of symp-
toms that might indicate cancer, are presented within
a biomedical frame of reference, as are the approaches to the
detection of these during medical assessment. Yet there is
evidence that lay views of health, symptoms and bodily changes
are experienced and expressed very differently to the way in
which medical professionals approach assessing the signs and
symptoms of ill health of individuals presenting in medical
encounters. Individuals focus more on personal practices and
responsibilities and this often has a strong moral dimension
relating to what one ‘should’ do to maintain health and practices
that will ward off ill health or help one return to full health.39
For some, poor health is seen to be due to ‘wrong’ living.
‘Keeping going’ and not letting things go are important drivers
underlying lay views of health. In the context of attempting to
speed the recognition of ill health that might indicate cancer,
these lay conceptions of health may act as barriers to presen-
tation. They may also conﬂict with the health professional’s
diagnostic agenda, further complicating the diagnostic process.
Perspectives that draw on an extensive literature relating to
social dimensions of health and illness have yet to be applied in
studies in the context of cancer. Furthermore, improved under-
standings of how lay views and consulting behaviour differ by
socioeconomic group would inform interventions to improve
cancer survival and thus address the socioeconomic gradient in
health outcomes.
A number of studies of the process of ‘becoming diagnosed’
with cancer has highlighted important social dimensions in the
way in which individuals respond to the possibility of ill health.
Shame and stigma are described as a core component of indi-
vidual responses to a diagnosis of lung cancer. For example, the
belief that health professionals will view an individual who
smokes and presents with chest-related symptoms as at fault
because of the association of lung cancer with smoking may
make individuals feel reluctant to seek help.40 Furthermore, the
identiﬁcation of social sanctioning (ie, the role played by lay
networks, health services and wider society in supporting and
prompting help-seeking) as an important factor in recent
systematic reviews, draws attention to the social nature of
individuals’ recognition of their own illness.23 If, as Radley and
Billig41 theorise, illness is viewed as an experience or condition
that can only be sustained in one’s mind as a possibility ‘against
the background of other competing moral demands’, it does not
appear surprising that the social sanctioning of ill health is
implicated in illness recognition as well as help-seeking.42
Understanding of the ways in which illness recognition can be
socially determined is emerging and suggests that a linear view
of illness recognition and help-seeking in which a person expe-
riences a symptom, recognises it as such and then presents it to
a primary care physician is too simplistic. When faced with
multiple possibilities for socially legitimate non-disease expla-
nations for changes in one’s health, and a need to legitimise
claims to ill health (L Brindle, PhD thesis, 2000),43 45 the inter-
pretation of a change in health as illness, or a symptom, is
evidently a socially mediated (or constructed) process.44 45 From
a perspective that treats symptom recognition as a social
process, the attribution of delay in presentation to individuals
and, therefore, a clear distinction between patient and health
practitioner ‘delay’, becomes problematical.42 45 46
Arguments such as these from medical sociology, and
a growing body of empirical research that demonstrates how the
micro-organisation of primary care consultations and the
terminology used by clinicians inﬂuences clinical outcomes,
support an argument for adopting research approaches such as
ethnography and ethnomethodology. These approaches set out
to understand how ill health becomes recognised as such within
social interactions. Such research involves the sociological anal-
yses of observations and recordings of naturally occurring
interactions between patients and health professionals, or
patients and family members, and focuses on the factors that
inﬂuence how individuals interpret and act in relation to their
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health and symptoms as observed within everyday interactions.
These approaches have the potential to inform the development
of interventions to improve earlier presentation and earlier
referral for investigation of symptoms. For example, the use of
an ethnomethodological approach has been proposed to improve
earlier lung cancer diagnosis by developing targeted interven-
tions to improve the elicitation of health changes in routine
clinical consultations involving those at increased risk.42
Other studies reveal difﬁculties for individuals in convincing
doctors that that their symptoms are serious and this reinforces
a developing literature relating to the complexity surrounding
help-seeking encounters with professionals. On the one hand
there is enormous difﬁculty for professionals in interpreting
often vague and commonly experienced symptoms to determine
which warrant referral for further investigation, and for indi-
viduals on the other hand, the challenge of being ‘convincing’ or
presenting one’s problem in a way that will ﬁt with a doctor ’s
biomedical frame of reference.47 48
The identiﬁcation of cancer-speciﬁc relationships between risk
factors and delayed diagnosis in systematic reviews of delay
might reﬂect the differing narratives associated with different
types of cancer. Moffat (Moffat J. Understanding the experience
of developing and being diagnosed with lung cancer: exploring
the potential of narrative. Unpublished PhD Thesis. University
of Southampton, 2007) suggests that the absence of a narrative
of lung cancer; a story or plot in which an individual can place
one’s self may be a part of why individuals delay presenting to
their doctor with symptoms that are subsequently found to be
caused by lung cancer. Corner et al22 reveal the difﬁculty for
individuals in interpreting bodily changes that are a prelude to
lung cancer as anything more than an inevitable part of getting
older and therefore to be expected. Tishelman and Sachs49
describe this process among women with cervical cancer as
a ‘subtle normalising experience’ that proceeds over time in
which symptoms may be legitimised and non-legitimised
through encounters with medical professionals. Andersen et al44
reveal how individuals ‘contain’ or minimise bodily sensations
by integrating these into culturally acceptable explanations of
bodily changes such as ‘heavy garden work’ or stress. They may
also disassociate themselves from lifestyles that might put
themselves at risk of cancer or other serious disease and, thus,
disregard disease explanations for ill health. A sense of obligation
to maintain normality allows individuals to put off interpreting
symptoms as requiring health care or investigation. The expe-
rience of ‘embodied’ ill health (ie, the physical sensation of ill
health)50 may be lacking for some cancers, not necessarily because
there are no symptoms, but because such symptoms or bodily
changes are not constructed socially into a commonly understood
frame of reference for individuals so that they can be recognised
and how one is meant to act in relation to them widely under-
stood. The social understanding surrounding a breast lump and
what one should do about it, for example, has now largely become
a socially understood condition as a result of media and public
health messages. This is not the case for many other cancers.
Further to the complexities of what prompts help-seeking and
the challenges surrounding individualeprofessional interactions
in recognising signs of ill health and appropriate and timely
action being taken by doctors, there are indications that the
wider social environment surrounding particular diseases may
also be important. Corner et al22 have suggested that a social
narrative that relates early symptomatic diagnosis to improved
survival has not as yet been constructed around diseases such as
lung cancer, and outlines the elements of what needs to be
present for the ‘social discovery’ of disease.51 These include lay
initiation in seeking help, a social movement demanding action,
professional agendas to champion the disease and strong
organisational or institutional backing. In the absence of these it
is argued that it is unlikely that a strong or effective environ-
ment for the identiﬁcation and management of a particular
illness condition is likely to be mobilised.
SOCIAL PROCESSES AND PROMOTING EARLIER DIAGNOSIS OF
CANCER: THE RESEARCH AGENDA
The contribution of individual behaviour to late presentation
and diagnosis of cancer and the social processes that create
this phenomenon is only now beginning to be recognised as
worthy of study. This is not least because evidence that avoid-
able, late diagnosis is a signiﬁcant factor in cancer survival
outcomes, even in cancers in which there is a well-organised
national screening programme with high participation, is only
just emerging.
There is increasing evidence that avoidable ‘delays’ before
diagnosis are a signiﬁcant factor in cancer survival outcomes.
Attempts to isolate individual from social, and primary care
physician from patient factors, have led to the identiﬁcation of
inconsistent relationships between ‘social factors’ and diagnostic
delay, with little explanation for these apparent relationships.
We suggest a new research agenda is required that sets out to
study in detail the processes by which individuals come to
recognise and act on health changes as a prelude to a cancer
diagnosis and how recognition occurs within, rather than inde-
pendently of, or in interaction with, a social context. This
What is already known on this subject
Avoidable delay in diagnosis is a significant factor in cancer
survival outcomes. Individuals may contribute to delayed diag-
nosis through not recognising symptoms or health changes that
are related to cancer or not seeking help for these promptly.
What this paper adds
The processes by which patients seek help for health changes
that might be symptoms of cancer and secure diagnostic
investigations is complex and do not relate solely to individual
patient or professional behaviours. The wider societal context in
which illness and disease is shaped and defined through medical
knowledge, belief systems and organisations is also important.
Social processes shape how symptoms are interpreted and
presented to doctors in consultations; these processes warrant
further exploration and investigation.
Policy implications
Research addressing the social processes involved in the timing
of diagnosis of cancer, and public health interventions informed
by this research, are urgently needed to address the problem of
late diagnosis.
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demands studies that employ contextually sensitive methods
using observational and participatory methods such as ethnog-
raphy or ethnomethodology.52e54 Here social action is observed
in situ as events arise in order to develop deep contextually
derived knowledge of the problem of late diagnosis. The ﬁndings
of detailed contextually situated insights into what promotes
and inhibits help-seeking seems a fruitful starting point for
developing and testing community-based interventions based on
whole systems thinking.
Insights derived through research developed through this
perspective could be applied in a variety of ways, for example:
community-based awareness programmes based on deep
knowledge of how symptoms are interpreted in everyday situ-
ations among particular communities and groups; re-engineering
health system pathways for diagnosis; the development of
innovative diagnostic decision tools that recognise the
complexities of symptom presentation; and ‘lay’ehealth prac-
titioner communication about early symptoms; as well as
population-based studies to elucidate risk factors for cancer that
incorporate understanding derived through the study of social
processes. This research agenda ﬁts within the ‘new’ approach to
public health research advocated by authors such as Paterson55
and Popay and Williams,56 who argue that epidemiology relies
too heavily on population data and survey work to develop an
understanding of patterns of disease while neglecting the social
dynamics involved in the epidemiology of disease. They suggest
that a powerful and untapped resource for understanding the
connection between social dynamics and ill health is held among
individuals and people who are ill.56 We believe that new,
innovative approaches to the pressing public health problem of
late diagnosis in cancer are waiting to be discovered through the
application of knowledge derived from ‘bottom-up’ observation
and investigation with people and communities that could
simultaneously be applied to the development and testing of
public health interventions.
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